Peptide based therapeutics and their use for the treatment of neurodegenerative and other diseases - 29/05/18
pages | 8 |
Iconographies | 2 |
Vidéos | 0 |
Autres | 0 |
Graphical abstract |
Highlights |
• | Peptides have antioxidant, antimicrobial and antithrombotic effects. |
• | Carnosine, defensins, dermcidin, and hepcidin as therapeutic peptides. |
• | Peptides based vaccines to be used with other compounds. |
• | Peptides inhibitors are used in neurodegenerative diseases. |
Abstract |
Bioactive peptides are actively involved in different biological functions and importantly contribute to human health, and the use of peptides as therapeutics has a long successful history in disease management. A number of peptides have wide-ranging therapeutic effects, such as antioxidant, antimicrobial, and antithrombotic effects. Neurodegenerative diseases are typically caused by abnormal aggregations of proteins or peptides, and the depositions of these aggregates in or on neurons, disrupt signaling and eventually kill neurons. During recent years, research on short peptides has advanced tremendously. This review offers a brief introduction to peptide based therapeutics and their application in disease management and provides an overview of peptide vaccines, and toxicity related issues. In addition, the importance of peptides in the management of different neurodegenerative diseases and their therapeutic applications is discussed. The present review provides an understanding of peptides and their applications for the management of different diseases, but with focus on neurodegenerative diseases. The role of peptides as anti-cancer, antimicrobial and antidiabetic agents has also been discussed.
Le texte complet de cet article est disponible en PDF.Abbreviations : NDs, AD, PD, SPPS, NAC, ACP, RBCs
Keywords : Neurodegenerative disorders, Anti-Cancer, Enzymes, Peptides, Peptide based vaccine, Stability
Plan
Vol 103
P. 574-581 - juillet 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?